Abich Financial Wealth Management LLC Arcellx, Inc. Transaction History
Abich Financial Wealth Management LLC
- $281 Billion
- Q3 2025
A detailed history of Abich Financial Wealth Management LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 750 shares of ACLX stock, worth $67,485. This represents 0.02% of its overall portfolio holdings.
Number of Shares
750Holding current value
$67,485% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
227Shares Held
52.7MCall Options Held
84KPut Options Held
195K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.35MShares$572 Million0.32% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$418 Million12.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.91MShares$352 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$316 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.05MShares$274 Million15.63% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.94B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...